About: Population Data-Driven Formulation of a COVID-19 Therapeutic

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Population Data-Driven Formulation of a COVID-19 Therapeutic Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Population Data-Driven Formulation of a COVID-19 Therapeutic
Creator	Campbell, Heather Cecil, Regan Lodder, Robert
Source	MedRxiv; Medline; PMC
abstract	This study is designed to utilize computer modeling of the US population through NHANES to reduce the need for preclinical formulation and toxicology studies of an Ebola anti-viral (BSN389) being repurposed for COVID-19, and to thereby speed the candidate therapeutic to the clinic.
has issue date	2020-07-27(xsd:dateTime)
bibo:doi	10.1101/2020.07.24.20161547
bibo:pmid	32743601
has license	cc-by-nc
sha1sum (hex)	7599cc23a2076a4d4dbb6ecbd57998136bb88c73
schema:url	https://doi.org/10.1101/2020.07.24.20161547
resource representing a document's title	Population Data-Driven Formulation of a COVID-19 Therapeutic
has PubMed Central identifier	PMC7386525
has PubMed identifier	32743601
schema:publication	medRxiv
resource representing a document's body	covid:7599cc23a2076a4d4dbb6ecbd57998136bb88c73#body_text
is schema:about of	named entity 'COVID-19' named entity 'COMPUTER MODELING' named entity 'POPULATION' named entity 'SPEED' named entity 'FDA' named entity 'Centers for Disease Control' named entity 'computer modeling' named entity 'COVID' named entity 'toxicology' named entity 'preclinical' named entity 'virus' named entity 'medRxiv' named entity 'GGO' named entity 'phase 0' named entity 'rapid test' named entity 'antibody tests' named entity 'virus' named entity 'Gilead' named entity 'serological tests' named entity 'polymerase chain reaction' named entity 'dexamethasone' named entity 'preclinical research' named entity 'virus' named entity 'cell surface' named entity 'preprint' named entity 'vaccines' named entity 'serological testing' named entity 'China' named entity 'antiviral drug' named entity 'medRxiv' named entity 'arthritis' named entity 'antibody testing' named entity 'animal testing' named entity 'IgM' named entity 'body weight' named entity 'COVID-19 vaccine' named entity 'drug repurposing' named entity 'medRxiv' named entity 'cyclodextrins' named entity 'toxicology' named entity 'United States' named entity 'ACE2' named entity 'Quidel Corporation' named entity 'cyclodextrin' named entity 'COVID-19 testing' named entity 'COVID' named entity 'preprint' named entity 'CC-BY-NC 4.0' named entity 'U.S.' named entity 'Cotrone' named entity 'mRNA' named entity 'virus' named entity 'cyclodextrin' named entity 'antigen' named entity 'supply chain' named entity 'cyclodextrin' named entity 'false negatives' named entity 'malaria' named entity 'CC-BY-NC 4.0' named entity 'genetic material' named entity 'scientific scrutiny' named entity 'IgG' named entity 'SARS-CoV-2' named entity 'Cyclodextrins' named entity 'toxicology' named entity 'medRxiv' named entity 'respiratory support' named entity 'virus' named entity 'COVID' named entity 'RNA' named entity 'COVID-19 test' named entity 'medRxiv' named entity 'nasopharyngeal' named entity 'preprint' named entity 'COVID-19' named entity 'preprint' named entity 'difficulty breathing' named entity 'vaccines' named entity 'preprint'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software